Evidence map›Paper›PMID 41599066›Full record

ArticlePathogens (Basel, Switzerland)2026

The Role of Routine Surveillance Cultures in Optimising Sepsis Management in High-Risk Patient Groups.

Jan Závora, Václava Adámková, Alžběta Studená, Gabriela Kroneislová

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jan ZávoraClinical Microbiology and ATB Centre, General University Hospital in Prague, 128 08 Prague, Czech Republic.ORCID 0000-0002-6238-6514
Václava AdámkováClinical Microbiology and ATB Centre, General University Hospital in Prague, 128 08 Prague, Czech Republic.ORCID 0000-0002-7629-5365
Alžběta StudenáClinical Microbiology and ATB Centre, General University Hospital in Prague, 128 08 Prague, Czech Republic.
Gabriela KroneislováClinical Microbiology and ATB Centre, General University Hospital in Prague, 128 08 Prague, Czech Republic.ORCID 0009-0005-3607-5498

Funding

The Ministry of Health of the Czech Republic: MH CZ - 369 DRO - VFN00064165
6 · The paper itself

Abstract

backgroundSepsis remains a leading cause of morbidity and mortality, particularly when caused by multidrug-resistant organisms (MDROs). Early identification of colonising or infecting pathogens may inform initial antimicrobial selection. Surveillance cultures, providing microbiological data prior to infection onset, could guide timely and targeted therapy. This retrospective study analysed routine surveillance culture results from patients with bloodstream infection (BSI) episodes, assessing pathogen prevalence, resistance phenotypes, and concordance with specimen type in haemato-oncology (HO) and acute care (AC) settings.

methodsData were retrieved from the institutional Laboratory Information System of the Department of Clinical Microbiology and ATB Centre, General University Hospital in Prague, covering 1 January to 31 December 2024. All positive blood cultures containing ESCAPE pathogens (excluding

resultsIn 2024, 6046 AC and 7267 HO surveillance cultures were performed; MDRO prevalence was 5% and 6.56%, respectively. ESBL-producing Enterobacterales predominated (AC 86.9%, HO 81.6%). In HO, BSI-causing Gram-negative and Gram-positive pathogens were frequently detected in rectal swabs, whereas in AC, concordance was higher with upper and lower respiratory tract samples. Rectal screening detected 100% of

conclusionsSurveillance culture utility varies by specimen type and clinical setting. In both HO and AC units, these cultures provided valuable insights into colonisation and resistance patterns, supporting early risk stratification and guiding initial therapy in high-risk patients.

Indexed as

BacteriaSepsisAnti-Bacterial AgentsBlood CultureDrug Resistance, Multiple, BacterialFemaleHumansPrevalenceRetrospective StudiesAnti-Bacterial Agentsblood culturemicrobiology screeningmultiresistant bacteriasepsissurveillance

Identifiers

PMID41599066
PMCPMC12845119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.